Sterile becaplermin gel vs. sterile placebo gel treatment 1
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Platelet-Derived Growth Factor
Conditions
Platelet-Derived Growth Factor, Diabetic Foot, Neoplasms
Trial Timeline
Jul 1, 1999 → Apr 1, 2001
NCT ID
NCT00740922About Sterile becaplermin gel vs. sterile placebo gel treatment 1
Sterile becaplermin gel vs. sterile placebo gel treatment 1 is a pre-clinical stage product being developed by Johnson & Johnson for Platelet-Derived Growth Factor. The current trial status is completed. This product is registered under clinical trial identifier NCT00740922. Target conditions include Platelet-Derived Growth Factor, Diabetic Foot, Neoplasms.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00740922 | Pre-clinical | Completed |